267 related articles for article (PubMed ID: 3066211)
41. Urethral meatal carcinoma following cystourethrectomy for bladder carcinoma.
Schellhammer PF; Whitmore WF
J Urol; 1976 Jan; 115(1):61-4. PubMed ID: 1246115
[TBL] [Abstract][Full Text] [Related]
42. [Chemotherapy for advanced bladder cancer: clinical evaluation of chemotherapy for locally advanced or metastatic bladder cancer and adjuvant chemotherapy for deeply invasive bladder cancer following radical cystectomy].
Uekado Y; Ogawa T; Yoshida T; Yamamoto S; Hirano A; Watanabe T; Shinka T; Ohkawa T
Hinyokika Kiyo; 1985 Aug; 31(8):1365-70. PubMed ID: 3841260
[TBL] [Abstract][Full Text] [Related]
43. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP
J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
[TBL] [Abstract][Full Text] [Related]
44. Clinical study on recurrence in bladder cancer patients undergoing total cystectomy--statistical analysis of factors related to recurrence.
Honda N; Yamada Y; Mitsui K; Mizumoto H; Taki T; Kamijyo A; Okada M; Hibi H; Fukatsu H
Hinyokika Kiyo; 1999 May; 45(5):317-24. PubMed ID: 10410313
[TBL] [Abstract][Full Text] [Related]
45. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base.
David KA; Milowsky MI; Ritchey J; Carroll PR; Nanus DM
J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135
[TBL] [Abstract][Full Text] [Related]
46. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
Karakiewicz PI; Shariat SF; Palapattu GS; Gilad AE; Lotan Y; Rogers CG; Vazina A; Gupta A; Bastian PJ; Perrotte P; Sagalowsky AI; Schoenberg M; Lerner SP
J Urol; 2006 Oct; 176(4 Pt 1):1354-61; discussion 1361-2. PubMed ID: 16952631
[TBL] [Abstract][Full Text] [Related]
47. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
Słojewski M
Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
[TBL] [Abstract][Full Text] [Related]
48. Urethral remnant tumors following simultaneous partial urethrectomy and cystectomy for bladder carcinoma.
Shinka T; Uekado Y; Aoshi H; Komura T; Ohkawa T
J Urol; 1989 Oct; 142(4):983-7. PubMed ID: 2795756
[TBL] [Abstract][Full Text] [Related]
49. Outcomes in patients with pathological carcinoma in situ only disease at radical cystectomy.
Hassan JM; Cookson MS; Smith JA; Johnson DL; Chang SS
J Urol; 2004 Sep; 172(3):882-4. PubMed ID: 15310989
[TBL] [Abstract][Full Text] [Related]
50. [Radical cystectomy in the treatment of invasive bladder cancer].
Shaplygin LV; Sitnikov NV; Furashov DV; Dronov VI; Deviatov AS; Sidorov VA
Voen Med Zh; 2003 Dec; 324(12):43-6. PubMed ID: 14982004
[No Abstract] [Full Text] [Related]
51. [Surgical treatment of recurrent urethral neoplasms after cystectomy for bladder carcinoma].
Cancrini A; Fattahi H; Marcellini M; De Carli P
Ann Ital Chir; 1979; 51(3):339-47. PubMed ID: 539676
[No Abstract] [Full Text] [Related]
52. [Inguinal lymph node metastasis of bladder carcinoma ten years after cystourethrectomy: a case report].
Nishimoto K; Oyama M; Ando T; Nakajima Y; Kiguchi H
Hinyokika Kiyo; 2005 Nov; 51(11):759-61. PubMed ID: 16363710
[TBL] [Abstract][Full Text] [Related]
53. [Recurrent urothelial cancer after resection of ureteral carcinoma].
Kong C; Ci J; Liu T
Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):465-7. PubMed ID: 10920948
[TBL] [Abstract][Full Text] [Related]
54. [Transitional cell carcinoma of the urinary bladder accompanied by signet-ring cell carcinoma: a case report].
Ozeki Z; Kobayashi S; Machida T; Ishizaka K; Oka T
Hinyokika Kiyo; 2003 Jul; 49(7):411-3. PubMed ID: 12968484
[TBL] [Abstract][Full Text] [Related]
55. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
Gohji K; Higuchi A; Maruyama S; Minayoshi K; Fujii A; Itoh N; Hasunuma Y; Tanaka H; Izumi T
Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
[TBL] [Abstract][Full Text] [Related]
56. Urethral carcinoma after cystectomy: the case for routine urethrectomy.
Clark PB
J Urol (Paris); 1984; 90(3):173-9. PubMed ID: 6491352
[TBL] [Abstract][Full Text] [Related]
57. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
Yu RJ; Stein JP; Cai J; Miranda G; Groshen S; Skinner DG
J Urol; 2006 Aug; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
[TBL] [Abstract][Full Text] [Related]
58. [Treatment results of total cystectomy for patients with bladder cancer].
Kanamaru H; Shirahase T; Moroi S; Kihara Y; Okuno H; Kuo JY; Taniguchi T; Arai Y; Tanaka Y; Okada Y
Hinyokika Kiyo; 1993 May; 39(5):433-8. PubMed ID: 8322625
[TBL] [Abstract][Full Text] [Related]
59. [Urethral recurrence of bladder cancer 16 years after total cystectomy. A case report].
Takayama H; Arai Y; Meguro N; Maeda O; Saiki S; Kinouchi T; Kuroda M; Usami M; Kotake T
Nihon Hinyokika Gakkai Zasshi; 1997 Aug; 88(8):762-5. PubMed ID: 9293753
[TBL] [Abstract][Full Text] [Related]
60. Prospective study of transitional cell carcinoma in the prostatic urethra and prostate in the cystoprostatectomy specimen. Incidence, characteristics and preoperative detection.
Liedberg F; Anderson H; Bläckberg M; Chebil G; Davidsson T; Gudjonsson S; Jahnson S; Olsson H; Månsson W
Scand J Urol Nephrol; 2007; 41(4):290-6. PubMed ID: 17763219
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
